Journal for ImmunoTherapy of Cancer,
Journal Year:
2020,
Volume and Issue:
8(2), P. e001222 - e001222
Published: Oct. 1, 2020
During
oncogenesis,
tumor
cells
present
specific
carbohydrate
chains
that
are
new
targets
for
cancer
immunotherapy.
Whereas
these
tumor-associated
carbohydrates
(TACA)
can
be
targeted
with
antibodies
and
vaccination
approaches,
TACA
including
sialic
acid-containing
glycans
able
to
inhibit
anticancer
immune
responses
by
engagement
of
receptors
on
leukocytes.
A
family
immune-modulating
acid-binding
Siglec
have
been
recently
described
antitumor
activity
mediated
myeloid
cells,
natural
killer
T
cells.
Other
TACA-binding
selectins
linked
progression.
Recent
studies
shown
glycan-lectin
interactions
improve
For
example,
between
the
checkpoint
cell
immunoglobulin
mucin-domain
containing-3
lectin
galectin-9
in
clinical
trials.
In
addition,
an
antibody
against
Siglec-15
is
being
tested
early
trial.
this
review,
we
summarize
previous
current
efforts
target
inhibitory
binding
Siglec-sialoglycan
axis.
Advanced Materials,
Journal Year:
2019,
Volume and Issue:
32(13)
Published: July 28, 2019
Development
of
drug-delivery
systems
that
selectively
target
neoplastic
cells
has
been
a
major
goal
nanomedicine.
One
strategy
for
achieving
this
milestone
is
to
install
ligands
on
the
surface
nanocarriers
enhance
delivery
tissues,
as
well
internalization
by
cells,
which
improves
accuracy,
efficacy,
and
ultimately
enhances
patient
outcomes.
Herein,
recent
advances
regarding
development
ligand-installed
are
introduced
effect
their
design
biological
performance
discussed.
Besides
academic
achievements,
progress
in
clinical
trials
presented,
along
with
challenges
faced
these
formulations.
Lastly,
future
perspectives
discussed,
particular
emphasis
potential
emerging
precision
therapies.
Journal of Clinical Investigation,
Journal Year:
2018,
Volume and Issue:
128(11), P. 4912 - 4923
Published: Aug. 21, 2018
First-generation
immune
checkpoint
inhibitors,
including
anti-CTLA-4
and
anti-programmed
death
1
(anti-PD-1)
antibodies,
have
led
to
major
clinical
progress,
yet
resistance
frequently
leads
treatment
failure.
Thus,
new
targets
acting
on
T
cells
are
needed.
CD33-related
sialic
acid-binding
immunoglobulin-like
lectins
(Siglecs)
pattern-recognition
receptors
binding
a
range
of
sialoglycan
ligands,
which
appear
function
as
self-associated
molecular
patterns
(SAMPs)
that
suppress
autoimmune
responses.
Siglecs
expressed
at
very
low
levels
normal
cells,
these
were
not
until
recently
considered
interesting
for
cancer
immunotherapy.
Here,
we
show
an
upregulation
Siglecs,
Siglec-9,
tumor-infiltrating
from
non-small
cell
lung
(NSCLC),
colorectal,
ovarian
patients.
Siglec-9-expressing
coexpressed
several
inhibitory
receptors,
PD-1.
Targeting
the
sialoglycan-SAMP/Siglec
pathway
in
vitro
vivo
resulted
increased
anticancer
immunity.
expression
Siglec-9
NSCLC
patients
correlated
with
reduced
survival,
polymorphisms
showed
association
risk
developing
colorectal
cancer.
Our
data
identify
potential
target
improving
activation
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: Sept. 6, 2019
Cell-cell
interactions
and
cell
adhesion
are
key
mediators
of
cancer
progression
facilitate
hallmarks
including
immune
evasion
metastatic
dissemination.
Many
molecules
within
the
tumor
microenvironment
changed
significant
alterations
glycosylation
observed.
These
changes
in
alter
ability
cells
to
interact
with
other
extracellular
matrix
proteins.
Three
families
cell-cell
interaction
selectins,
Siglecs,
integrins
have
been
associated
many
pre-clinical
studies,
yet
inhibition
as
a
therapeutic
target
is
just
beginning
be
explored.
We
review
how
mediated
by
glycan-binding
receptors
selectins
Siglec
support
progression.
The
discussion
focuses
on
mechanisms
during
metastasis
that
can
therapeutically
targeted
blocking
these
interactions.
Chemical Reviews,
Journal Year:
2021,
Volume and Issue:
121(18), P. 10950 - 11029
Published: Aug. 2, 2021
Carbohydrates
are
the
most
abundant
and
one
of
important
biomacromolecules
in
Nature.
Except
for
energy-related
compounds,
carbohydrates
can
be
roughly
divided
into
two
categories:
as
matter
information.
As
matter,
abundantly
present
extracellular
matrix
animals
cell
walls
various
plants,
bacteria,
fungi,
etc.,
serving
scaffolds.
Some
commonly
found
polysaccharides
featured
biocompatible
materials
with
controllable
rigidity
functionality,
forming
polymeric
biomaterials
which
widely
used
drug
delivery,
tissue
engineering,
etc.
information,
usually
referred
to
glycans
from
glycoproteins,
glycolipids,
proteoglycans,
bind
proteins
or
other
carbohydrates,
thereby
meditating
cell–cell
cell–matrix
interactions.
These
could
simplified
synthetic
glycopolymers,
afforded
through
polymerization,
multistep
synthesis,
a
semisynthetic
strategy.
The
information
role
demonstrated
not
only
targeting
reagents
but
also
immune
antigens
adjuvants.
latter
included
this
review
they
always
macromolecular
formulation.
In
review,
we
intend
provide
relatively
comprehensive
summary
carbohydrate-based
since
2010
while
emphasizing
fundamental
understanding
guide
rational
design
biomaterials.
Carbohydrate-based
macromolecules
on
basis
their
resources
chemical
structures
will
discussed,
including
naturally
occurring
polysaccharides,
derived
glycopolymers/glycodendrimers,
supramolecular
glycolipids/glycoproteins.
Multiscale
structure–function
relationships
several
major
application
areas,
delivery
systems,
immunology,
detailed.
We
hope
valuable
development
build
bridge
between
promote
new
biomaterial
near
future.
Accounts of Chemical Research,
Journal Year:
2019,
Volume and Issue:
52(11), P. 3108 - 3119
Published: Oct. 10, 2019
ConspectusInterest
in
increasing
drug
delivery
efficiency
has
risen
over
the
past
decade
both
as
a
means
to
improve
efficacy
of
already
clinically
available
drugs
and
due
increased
difficulties
approving
new
drugs.
As
functional
group
for
targeted
delivery,
boronic
acids
(BAs)
have
been
incorporated
polymeric
particles
stimuli-responsive
targeting
ligand.
Here,
BA
chemistry
presents
wealth
opportunities
biological
applications.
It
not
only
reacts
with
several
chemical
markers
disease
such
reactive
oxygen
species
(ROS),
adenosine
triphosphate
(ATP),
glucose,
reduced
pH,
but
it
also
acts
ligands
diols
sialic
acid.
These
systems
optimize
therapeutics
based
on
rational
design
precise
molecular
engineering.
When
designing
materials
containing
BA,
unique
properties
are
important
take
into
consideration
its
vacant
p-orbital,
geometry,
designed
acid's
pKa.
Instead
behaving
most
carboxylic
that
donate
protons,
BAs
instead
primarily
act
Lewis
accept
electrons.
In
aqueous
solution,
polymers
exist
an
equilibrium
between
their
triangular
hydrophobic
form
tetrahedral
hydrophilic
form.
The
common
pKa's
nonphysiological
range
8–10,
much
ongoing
research
focuses
modifying
sensitive
more
physiologically
relevant
pH
range.
So
far,
moieties
stunning
array
materials,
ranging
from
small
molecules
can
self-assemble
higher
order
structures
micelles
micelles,
via
larger
assemblies,
large
scale
hydrogels.
With
abundance
polyhydroxy
motifs,
BA-containing
proven
valuable
biomedical
applications
treatment
cancer,
diabetes,
obesity,
bacterial
infections.
Both
functionalized
esters
display
good
safety
profiles
vitro
vivo;
thus,
represent
promising
carriers
responsive
great
potential
clinical
translation.The
intention
this
Account
is
showcase
versatility
We
first
discuss
what
consider
when
materials.
Further,
we
review
how
recently
applied
nanomaterials
enhanced
efficiency,
Lastly,
current
limitations
further
perspectives
biomaterials,
benefits
come
utilizing
enhance
efficiency.
Cancers,
Journal Year:
2018,
Volume and Issue:
10(6), P. 207 - 207
Published: June 18, 2018
Cell
surface
glycosylation
is
dynamic
and
often
changes
in
response
to
cellular
differentiation
under
physiological
or
pathophysiological
conditions.
Altered
on
cancers
cells
gaining
attention
due
its
wide-spread
occurrence
across
a
variety
of
cancer
types
recent
studies
that
have
documented
functional
roles
for
aberrant
driving
progression
at
various
stages.
One
change
can
correlate
with
stage
disease
prognosis
hypersialylation.
Increased
levels
sialic
acid
are
pervasive
growing
body
evidence
demonstrates
how
hypersialylation
advantageous
cells,
particularly
from
the
perspective
modulating
immune
cell
responses.
Sialic
acid-binding
receptors,
such
as
Siglecs
Selectins,
well-positioned
be
exploited
by
Evidence
also
mounting
modulate
key
tumor
microenvironment,
those
responsible
maintaining
appropriate
inflammatory
environment.
From
these
come
new
innovative
ways
block
effects
directly
reducing
blocking
interactions
between
Selectins.
Here
we
review
works
examining
become
hypersialylated,
benefits
tumors,
proposed
therapies
abrogate
cancer.